ArticleJournal of human immunity2026
CRISPR/Cas9-mediated loss of FERMT3 reveals kindlin-3-independent neutrophil activity in LAD-III.
Article in Journal of human immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Mutations in human FERMT3 (encoding kindlin-3 protein) impair β2 integrin activity in neutrophils from patients with leukocyte adhesion deficiency III (LAD-III). Yet kindlin-3's contribution to neutrophil integrin affinity regulation and function remains unclear. Using CD34+ human hematopoietic stem and progenitor cells (HSPCs) differentiated into neutrophils, we investigated how CRISPR/Cas9-mediated kindlin-3 deletion affects neutrophil characteristics. CRISPR/Cas9 targeting FERMT3 resulted in an ∼80-bp deletion within exon 2, impairing protein production. FERMT3 KO neutrophils retained normal in vitro development and phenotype with similar surface marker expression, nuclear morphology, and expansion potential compared with untreated cultured neutrophils. Loss of kindlin-3 abolished zymosan-induced NADPH oxidase activity, recapitulating the ROS production defect of LAD-III neutrophils. However, although basal adhesion was reduced, stimulus-induced integrin activity remained largely intact. FERMT3 KO neutrophils retained fMLP-driven chemotaxis while showing impaired migration in response to C5a. Together, these findings show that disruption of kindlin-3 largely recapitulates the LAD-III phenotype while exerting some effector functions upon stimulation without intact kindlin-3.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.